Vericel Corporation Shares Purchased by Lisanti Capital Growth LLC
VCEL Stock | USD 36.82 0.76 2.02% |
About 58% of Vericel Corp's investor base is looking to short. The analysis of the overall investor sentiment regarding Vericel Corp Ord suggests that many traders are alarmed. Vericel Corp's investing sentiment shows overall attitude of investors towards Vericel Corp Ord.
Lisanti Capital Growth LLC increased its position in shares of Vericel Corporation by 53.4 percent in the first quarter, according to its most recent Form 13F filing with the Securities Exchange Commission. The firm owned ,015 shares of the biotechnology companys stock after purchasing an additional 13,585 shares during the quarter.
Read at thelincolnianonline.com
![]() |
Vericel Corp Ord Current Investor Sentiment
Comfort Level 42
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Vericel Corp's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Vericel Corp Ord.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Vericel Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Vericel Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Vericel Corp Ord Historical Investor Sentiment
Investor biases related to Vericel Corp's public news can be used to forecast risks associated with an investment in Vericel. The trend in average sentiment can be used to explain how an investor holding Vericel can time the market purely based on public headlines and social activities around Vericel Corp Ord. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vericel Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vericel Corp and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Vericel Corp news discussions. The higher the estimate score, the more favorable the investor's outlook on Vericel Corp.
Vericel Corp Fundamental Analysis
We analyze Vericel Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Vericel Corp is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Vericel Corp Ord Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vericel Corp stock to make a market-neutral strategy. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics with similar companies.
Peers
Vericel Corp Related Equities
SNDX | Syndax Pharmaceuticals | 21.10 | ||||
VCYT | Veracyte | 2.88 | ||||
RNA | Avidity Biosciences | 2.46 | ||||
XNCR | Xencor | 0.38 | ||||
RGNX | Regenxbio | 0.48 | ||||
MDWD | Mediwound | 0.86 | ||||
PTCT | PTC Therapeutics | 2.18 | ||||
OCUL | Ocular Therapeutix | 2.83 |
Check out Vericel Corp Hype Analysis, Vericel Corp Correlation and Vericel Corp Performance. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.476 | Earnings Share 0.15 | Revenue Per Share | Quarterly Revenue Growth 0.201 | Return On Assets |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.